Investor Relations

SEC Filings

Form 8-K
MILLENDO THERAPEUTICS, INC. filed this Form 8-K on 12/13/2018
Document Outline
Entire Document (273.3 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01. Entry into a Material Definitive Agreement.
Page 3 - Item 3.02. Unregistered Sales of Equity Securities.
Page 4 - Item 5.01. Changes in Control of Registrant.
Page 5 - Louis J. Arcudi III
Page 6 - Jeffery M. Brinza, J.D.
Page 7 - Sub Plan ), which will govern awards of stock options intended to qualify for favorable French incom
Page 8 - N/A
Page 9 - SIGNATURES
Subdocument 2 - EX-3.1 - EX-3.1
Page 1 - Exhibit 3.1
Page 2 - N/A
Subdocument 3 - EX-3.2 - EX-3.2
Page 1 - N/A
Subdocument 4 - EX-10.1 - EX-10.1
Page 1 - Exhibit 10.1
Page 2 - WHEREAS, Indemnitee does not regard the protection available under the Company s Bylaws and Certific
Page 3 - Appointing Stockholder ), and (ii) the Appointing Stockholder is, or is threatened to be made, a par
Page 4 - N/A
Page 5 - N/A
Page 6 - Independent Counsel as defined in Section 13 of this Agreement, and the objection shall set forth wi
Page 7 - N/A
Page 8 - N/A
Page 9 - Fund Indemnitors ). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., i
Page 10 - N/A
Page 11 - Corporate Status describes the status of a person who is or was a director, officer, employee, agent
Page 12 - Disinterested Director means a director of the Company who is not and was not a party to the Proceed
Page 13 - N/A
Page 14 - Delaware Court ), and not in any other state or federal court in the United States of America or any
Page 15 - N/A
Subdocument 5 - EX-10.5 - EX-10.5
Page 1 - Exhibit 10.5
Page 2 - 21.3. Eligibility
Page 3 - 21.5. Transfer restrictions
Page 4 - 21.7. Data Protection
Subdocument 6 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - About Millendo s Lead Programs
Page 3 - Cautionary Statement Regarding Forward-Looking Statements
Page 4 - Millendo Investor Contact: